MAPT and Alzheimer disease: Studies using positron emission tomography (PET) have reported that microglial activation, as assessed by 11C-PBR28, correlates with accumulation of amyloid (18F-flutemetamol) more so in MCI, compared with tau (18F-AV1451) where the correlation is stronger in established AD (Dani et al., 2018).